In lung cancer, high levels of cytoplasmic PRMT5 are correlated with a higher grade and poorer prognosis in aggressive non-small-cell lung carcinomas, whereas nuclear PRMT5 is more frequently detected in non-aggressive carcinoid tumors [48]. Here, PRMT5 is linked to lung cancer.